Adjuvant polyarthritis. vii. The role of type ii collagen in pathogenesis
Open Access
- 1 November 1982
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 25 (11) , 1325-1332
- https://doi.org/10.1002/art.1780251108
Abstract
The development of immune response in rats directed toward EL4 cells, after the injection of EL4 cells suspended in a saline/oil emulsion, was enhanced by the incorporation of Mycobacterium into the saline/oil emulsion; the incorporation of type II collagen into the saline–acetic acid/oil emulsion in concentrations ranging from 0.5–25 μg/ml had no apparent effect on the development of immune response. The incorporation of type II collagen into the saline–acetic acid/oil emulsion at higher concentrations (100 μg and 1.0 mg/ml) significantly suppressed both the humoral and the cell-mediated immune response. Pretreatment of rats with the maximal subarthritogenic dose of complete Freund's adjuvant prevented the development of arthritis in response to a subsequent injection of an arthritogenic dose of the same adjuvant, but had no effect on the development of type II collagen–induced arthritis. These observations suggest that adjuvant arthritis and the type II collagen–induced arthritis are distinctly different diseases.This publication has 36 references indexed in Scilit:
- Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.The Journal of Experimental Medicine, 1981
- Autoimmunity to collagen in adjuvant arthritis of rats.Journal of Clinical Investigation, 1980
- Passive Transfer by Cells of Type II Collagen-Induced Arthritis in RatsJournal of Clinical Investigation, 1978
- Adjuvant polyarthritisArthritis & Rheumatism, 1977
- Preparation of Various Fractions from Mycobacterium smegmatis, Their Arthritogenicity and Their Preventive Effect on Adjuvant DiseaseInternational Archives of Allergy and Immunology, 1976
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- Evidence for an endogenous antigen in the adjuvant arthritic ratThe Journal of Pathology, 1973
- SUPPRESSION OF ADJUVANT DISEASE IN THE RAT BY HETEROLOGOUS ANTILYMPHOCYTE GLOBULINThe Journal of Experimental Medicine, 1968
- Studies of the Mechanism whereby Adjuvant Disease is Suppressed in Rats Pretreated with MycobacteriaInternational Archives of Allergy and Immunology, 1967
- Experimental joint disease: Observations on adjuvant-induced arthritisJournal of Chronic Diseases, 1963